First, due to database limitations, the clinicopathological characteristics did not contain molecular markers, such as HER-2 status, mismatch repair deficiency, Epstein-Barr virus, and PD-1/PD-L1 expression. The gene discussed is ERBB2; the disease is mismatch repair cancer syndrome 1.